The company is now one of Australia's leading vaccine manufacturers with strong collaborative research with Australian Universities and institutions and exports its novel live vaccines globally.
Using a unique business model based on product specified collaborative research in Australian institutions, in house R&D, scale up, regulatory management, savvy market knowledge and an extensive personal network, the company is now Australia's leading privately owned veterinary biological vaccine company.
He has had an association with the San since his birth at the hospital in 1955 as have his parents, who have provided voluntary service over decades. He brings to the Board a passion for establishing sustainable long term financial support of the San's unique, patient focused care through the fundraising work of the Foundation.
In May 2008 he was awarded a Doctor of Applied Science, Honoris causa from RMIT in recognition of his role in commercialising Australian R&D.